Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.72 |
| ▸ | RAB9A | P51151 | 5/20 | 0.72 |
| ▸ | TP53 | P04637 | 3/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.72 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.72 |
| ▸ | RELA | Q04206 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.64 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.61 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.61 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL405087 | 0.85 | NPC1 (0.69) | NPC1SMN1; SMN2RAB9ATP53LMNA | |
| SCHEMBL4121731 | 0.84 | MAPT (0.72) | NPC1SMN1; SMN2RAB9ATP53LMNA | |
| SCHEMBL259430 | 0.84 | NPC1 (1.00) | NPC1SMN1; SMN2RAB9ATP53NFKB1 | |
| SCHEMBL10294777 | 0.84 | NPC1 (0.79) | NPC1SMN1; SMN2RAB9ATP53LMNA | |
| SCHEMBL6579950 | 0.83 | NPC1 (0.73) | NPC1SMN1; SMN2RAB9ATP53LMNA | |
| SCHEMBL8361562 | 0.82 | NPC1 (0.78) | NPC1SMN1; SMN2RAB9ATP53LMNA | |
| SCHEMBL259706 | 0.82 | MEN1 (0.77) | NPC1SMN1; SMN2RAB9ATP53NFKB1 | |
| SCHEMBL14632524 | 0.82 | NPC1 (0.74) | NPC1SMN1; SMN2RAB9ATP53NFKB1 | |
| SCHEMBL13719121 | 0.81 | MEN1 (0.67) | NPC1SMN1; SMN2RAB9ATP53NFKB1 | |
| SCHEMBL14372400 | 0.81 | CA1 (0.66) | NPC1SMN1; SMN2RAB9ATP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120065247-A1 | MODULATING IRES-MEDIATED TRANSLATION | DISCOVERYBIOMED, INC. (US) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065247-A1 | MODULATING IRES-MEDIATED TRANSLATION | EIF2AK2, EIF4EBP1, EIF4E | NPC1 2519/4885SMN1; SMN2 1695/4885RAB9A 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.